drugset / Trial / NCT05386368
RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients
RandomizedSingle-groupTriple-blindTreatment
Summary
To determine whether following Carbon dioxide (CO2) laser treatment, application of autologous cell suspension obtained via enzymatic and mechanical preparation will reduce negative side effects from CO2 laser and decrease the time of healing following treatment.
Timeline
- Start
- 2023-03-22
- Primary completion
- 2023-07-07
- Completion
- 2024-05-06
Outcome
Outcome not reported
Stopped (Enrollment): “Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. PI decided to terminate due to slow enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ReCell | Cell therapy | — | — |
Indications
No indication recorded.